Quick Reference Guide - MRSA Topical Eradication
Extravasation Oxaliplatin is an exfoliant (Group 4). ... management and prognosis is not particularly strong. Coronary artery spasm is more common in patients receiving continuous infusions of fluorouracil, and is usually ... Quick Reference Guide - …
Download Quick Reference Guide - MRSA Topical Eradication
Information
Domain:
Source:
Link to this page:
Documents from same domain
Carboplatin and Etoposide (lung) - SWAG Cancer Alliance
www.swagcanceralliance.nhs.ukThe North London Cancer Network. Dose adjustments in renal impairment. January 2009. Written/reviewed by: Dr A Dangoor (Consultant Oncologist, UHBristol NHS Trust), Dr P Jankowska (Consultant Oncologist, Taunton and Somerset NHS Trust) Checked by: Sarah Murdoch (Senior Oncology Pharmacist, SW Strategic Clinical Network), Kate Gregory (Lead
Cetuximab and Encorafenib - SWAG Cancer Alliance
www.swagcanceralliance.nhs.ukVersion 1 Review date Jan 2024 Page 4 of 8 Interrupt cetuximab and/or encorafenib in severe skin reactions (grade 3 acneiform rash). Cetuximab may only be
Daratumumab, bortezomib & dexamethasone (DVd)
www.swagcanceralliance.nhs.ukSubcutaneous daratumumab Administer via sub-cutaneous injection over 5 minutes. Patients should be observed for at least 6 hours after the end of the SC injection following the first dose (or as per local policy) and, if deemed necessary, after subsequent injections. Pre-medication 1-3 hours prior to daratumumab infusion (or subcutaneous ...
Quick Reference Guide - MRSA Topical Eradication
www.swagcanceralliance.nhs.ukWritten/reviewed by: Dr Lisa Lowry (Consultant Haematologist, UH Bristol NHS Trust) Checked by: Sarah Murdoch (Senior Oncology Pharmacist, SW Strategic Clinical Network) Authorised by: Dr J Braybrooke (Consultant Oncologist, UHBristol NHS Trust, SW Strategic Clinical Network) Date: September 2015
Trastuzumab emtansine – Kadcyla®
www.swagcanceralliance.nhs.ukDrug Induced Liver Injury (DILI) Serum transaminases > 3 x ULN and concomitant total bilirubin > 2× ULN Permanently discontinue Kadcyla in the absence of another likely cause for the elevation of liver enzymes and bilirubin, e.g. liver metastasis or concomitant medication
BEP 500 (Bleomycin, Etoposide and Cisplatin)
www.swagcanceralliance.nhs.ukVersion 2 Review date December 2021 Page 1 of 6 _____ Indication First line chemotherapy for good prognosis metastatic germ cell cancer (non-seminoma, combined or seminoma) – 3 cycles. First line chemotherapy for intermediate/poor prognosis metastatic germ cell cancer – 4 cycles (the 5-day schedule is usually preferred for this group). ICD ...
FOLFIRI - Irinotecan and Modified de Gramont Fluorouracil ...
www.swagcanceralliance.nhs.ukWarfarin/coumarin anticoagulants: Avoid use due to elevations in INR. Switch to low molecular weight heparin during treatment. Irinotecan: Irinotecan is a major substrate of cytochrome P450 CYP2B6 and CYP3A4 and as such levels of irinotecan may be reduced by medicines that induce levels of these enzymes.
Related documents
GUIDE TO EXTRAVASATION MANAGEMENT IN ADULT & …
emcrit.orgGUIDE TO EXTRAVASATION MANAGEMENT IN ADUL T & PEDIATRIC PATIENTS. Large, well-designed, controlled clinical trials in humans are not available to support the development of extravasation management guidelines. Available data generally consists o. f case reports, trials utilizing animal models, and small studies with evidence of poor or ...
CE 110 - A Guide to Clinical Differential Diagnosis of ...
res.cloudinary.comA Guide to Clinical Differential Diagnosis of Oral Mucosal Lesions Continuing Education ... The first step in successful therapeutic management of a ... Parulis/sinus track Periodontal abscess Mucocele (mucous extravasation phenomenon) Fibrous hyperplasia Inflammatory papillary hyperplasia Necrotizing sialometaplasia ...
Status epilepticus guideline
www.thewaltoncentre.nhs.ukIV access due to risk of extravasation and phlebitis. Preferred if Avoid if Levetiracetam (Keppra) - Polypharmacy (fewest ... quality randomised controlled trial evidence to guide treatment decisions. • Look for an underlying cause and treat ... This guideline will focus on the management of tonic-clonic status epilepticus.
CARFILZOMIB /DEXAMETHASONE (CarDex)
nssg.oxford-haematology.org.ukEXTRAVASATION RISK: Carfilzomib is not known to be a vesicant. There are no data available regarding skin corrosion/irritation or extravasation. Follow institution’s guideline on management of extravasation events in the event of carfilzomib extravasation. MHRA alert: risk of reactivation of hepatitis B virus:
BORTEZOMIB THALIDOMIDE AND DEXAMETHASONE …
nssg.oxford-haematology.org.ukExtravasation risk: Irritant: bortezomib EMETIC RISK Low ADVERSE EFFECTS/REGIEMN SPECIFIC COMPLICATIONS • Teratogenic: The Pregnancy Prevention Programme must be observed for all male and female patients. Prescribing and dispensing of thalidomide must be in line with the pregnancy prevention programme.